CVE-2026-71129: Oracle VM VirtualBox · Improper Access Control
Affects Oracle VM VirtualBoxSource CVE Database V5
Not known to be exploited · CVSS 8.2 High.
Data as of 16 Nov 2026, 20:25 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 7% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 18 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle VM VirtualBox | Affected
| Fixed in– |
AI-suggested
Oracle has released a Critical Security Patch Update (CSPU) in August 2026 addressing this and many other vulnerabilities. Customers are strongly advised to apply the available security patches promptly and remain on actively supported versions. Since the affected version is 7.2.14, upgrading to a patched version beyond 7.2.14 is recommended. No specific patch link was provided in the input, so users should consult the Oracle advisory at https://www.oracle.com/security-alerts/cspuaug2026.html for detailed patch availability and installation instructions.
Description
CVE-2026-71129 is a high-severity vulnerability in Oracle VM VirtualBox version 7.2.14. It allows a high privileged attacker with logon access to the infrastructure running VirtualBox to compromise the product, potentially leading to full takeover. The vulnerability impacts confidentiality, integrity, and availability, and may affect additional products due to scope change.